Status: Recruiting
Safety and Efficacy of the CoolCryo System for Cardiac Cryoablation in the Treatment of Atrial Fibrillation
The study involves endocardial cryoablation of the left and/or right atrium of the heart using the CoolCryo system as an adjunct to mitral valve surgery, with the aim of eliminating atrial fibrillation (AF), which is a common sequelae of mitral valve defects and is associated with an increased risk of ischaemic stroke, heart failure and death.
Participants needed: 20
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Medinice S.A.Updated: Sep 23, 2025Locations: 2
Eligibility criteria
Written consent from the patient to participate in the study. [+3]
Lack of written consent from the patient to participate in the study. [+12]